A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events - The Lancet - 1996
Brief Summary:
Clopidogrel reduces CV outcomes more than aspirin when used as secondary prevention among patients with prior stroke or MI.Reference: http://www.ncbi.nlm.nih.gov/pubmed/8918275
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you